176 related articles for article (PubMed ID: 25136636)
21. Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer.
Chen KC; Chen HY; Chen CY
Evid Based Complement Alternat Med; 2014; 2014():436863. PubMed ID: 24868239
[TBL] [Abstract][Full Text] [Related]
22. Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?
Chen KC; Chang SS; Tsai FJ; Chen CY
J Biomol Struct Dyn; 2013; 31(11):1219-35. PubMed ID: 23146021
[TBL] [Abstract][Full Text] [Related]
23. [Structure of the Smoothened receptor].
Ruat M; Hoch L; Faure H; Rognan D
Med Sci (Paris); 2013 Oct; 29(10):855-60. PubMed ID: 24148123
[TBL] [Abstract][Full Text] [Related]
24. Lose weight with traditional chinese medicine? Potential suppression of fat mass and obesity-associated protein.
Chang PC; Wang JD; Lee MM; Chang SS; Tsai TY; Chang KW; Tsai FJ; Chen CY
J Biomol Struct Dyn; 2011 Dec; 29(3):471-83. PubMed ID: 22066534
[TBL] [Abstract][Full Text] [Related]
25. The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation.
Carroll CE; Marada S; Stewart DP; Ouyang JX; Ogden SK
Development; 2012 Feb; 139(3):612-21. PubMed ID: 22223683
[TBL] [Abstract][Full Text] [Related]
26. In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease.
Chen KB; Chen KC; Chang YL; Chang KL; Chang PC; Chang TT; Chen YC
Molecules; 2016 May; 21(5):. PubMed ID: 27164068
[TBL] [Abstract][Full Text] [Related]
27. Evidence for allosteric interactions of antagonist binding to the smoothened receptor.
Rominger CM; Bee WL; Copeland RA; Davenport EA; Gilmartin A; Gontarek R; Hornberger KR; Kallal LA; Lai Z; Lawrie K; Lu Q; McMillan L; Truong M; Tummino PJ; Turunen B; Will M; Zuercher WJ; Rominger DH
J Pharmacol Exp Ther; 2009 Jun; 329(3):995-1005. PubMed ID: 19304771
[TBL] [Abstract][Full Text] [Related]
28. Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists.
Lucas BS; Aaron W; An S; Austin RJ; Brown M; Chan H; Chong A; Hungate R; Huang T; Jiang B; Johnson MG; Kaizerman JA; Lee G; McMinn DL; Orf J; Powers JP; Rong M; Toteva MM; Uyeda C; Wickramasinghe D; Xu G; Ye Q; Zhong W
Bioorg Med Chem Lett; 2010 Jun; 20(12):3618-22. PubMed ID: 20493695
[TBL] [Abstract][Full Text] [Related]
29. In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.
Chen KC; Sun MF; Chen CY
Evid Based Complement Alternat Med; 2014; 2014():917605. PubMed ID: 24876881
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine.
Chang YL; Chen HY; Chen KB; Chen KC; Chang KL; Chang PC; Chang TT; Chen YC
SAR QSAR Environ Res; 2016 Jul; 27(7):589-608. PubMed ID: 27218135
[TBL] [Abstract][Full Text] [Related]
31. Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis.
Wang W; Wan M; Liao D; Peng G; Xu X; Yin W; Guo G; Jiang F; Zhong W; He J
Biomed Res Int; 2017; 2017():4751780. PubMed ID: 29147652
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity.
Sinha N; Chowdhury S; Sarkar RR
Proteins; 2020 Mar; 88(3):514-526. PubMed ID: 31589795
[TBL] [Abstract][Full Text] [Related]
33. Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocation.
Wang Y; Arvanites AC; Davidow L; Blanchard J; Lam K; Yoo JW; Coy S; Rubin LL; McMahon AP
ACS Chem Biol; 2012 Jun; 7(6):1040-8. PubMed ID: 22554036
[TBL] [Abstract][Full Text] [Related]
34. Converse conformational control of smoothened activity by structurally related small molecules.
Yang H; Xiang J; Wang N; Zhao Y; Hyman J; Li S; Jiang J; Chen JK; Yang Z; Lin S
J Biol Chem; 2009 Jul; 284(31):20876-84. PubMed ID: 19366682
[TBL] [Abstract][Full Text] [Related]
35. Discovery, molecular and pharmacological characterization of GSA-10, a novel small-molecule positive modulator of Smoothened.
Gorojankina T; Hoch L; Faure H; Roudaut H; Traiffort E; Schoenfelder A; Girard N; Mann A; Manetti F; Solinas A; Petricci E; Taddei M; Ruat M
Mol Pharmacol; 2013 May; 83(5):1020-9. PubMed ID: 23448715
[TBL] [Abstract][Full Text] [Related]
36. De novo design of dual-target JAK2, SMO inhibitors based on deep reinforcement learning, molecular docking and molecular dynamics simulations.
He L; Liu J; Zhao HL; Zhang LC; Yu RL; Kang CM
Biochem Biophys Res Commun; 2023 Jan; 638():23-27. PubMed ID: 36436338
[TBL] [Abstract][Full Text] [Related]
37. Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms.
He X; Zhao L; Zhong W; Chen HY; Shan X; Tang N; Chen CY
Biomed Pharmacother; 2020 Sep; 129():110360. PubMed ID: 32559623
[TBL] [Abstract][Full Text] [Related]
38. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.
Chang SS; Huang HJ; Chen CY
Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120
[TBL] [Abstract][Full Text] [Related]
39. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.
Frank-Kamenetsky M; Zhang XM; Bottega S; Guicherit O; Wichterle H; Dudek H; Bumcrot D; Wang FY; Jones S; Shulok J; Rubin LL; Porter JA
J Biol; 2002 Nov; 1(2):10. PubMed ID: 12437772
[TBL] [Abstract][Full Text] [Related]
40. Smoothened variants explain the majority of drug resistance in basal cell carcinoma.
Atwood SX; Sarin KY; Whitson RJ; Li JR; Kim G; Rezaee M; Ally MS; Kim J; Yao C; Chang AL; Oro AE; Tang JY
Cancer Cell; 2015 Mar; 27(3):342-53. PubMed ID: 25759020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
